TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc, (NASDAQ:ABPI) appointed William S. Poole to serve as a member of the Company’s Board of Directors. Mr. Poole will serve as a Class III Director requiring re-election at the next annual meeting of stockholders and will bring the number of Board members to eight.
